Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation James A. Stone, MD,

Slides:

Advertisements

Similar presentations

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Advertisements

Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.

La néphropathie chronique en présence de diabète Canadian Journal of Diabetes Volume 37, Pages S504-S512 (October 2013) DOI: /j.jcjd

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Low atrial septal pacing with dual-chamber pacemakers reduces atrial fibrillation in sick sinus syndrome Hitoshi Minamiguchi, MD, Shinsuke Nanto, MD, PhD,

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Impact of End-Stage Kidney Disease on Academic Achievement and Employment in Young Adults: A Mixed Methods Study Peter D. Murray, Fabienne Dobbels, Ph.D.,

Health Benefits of Nordic Walking

Current and Future Status of Extracorporeal Cardiopulmonary Resuscitation for In- Hospital Cardiac Arrest Rohit K. Singal, MD, MSc, Deepa Singal, MSc,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC

Adolescent Tdap Vaccine Use Among Primary Care Physicians

Anticoagulation Regimens During Pregnancy in Patients With Mechanical Heart Valves: A Systematic Review and Meta-analysis Zhe Xu, MD, PhD, Jin Fan, MD,

New-onset Atrial Fibrillation Predicts Heart Failure Progression

171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.

A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.

A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.

Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention

Frontiers of anticoagulation therapy for atrial fibrillation

The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence David D. Waters, MD, Sripal Bangalore, MD,

The Demise of Morphine Oxygen Nitroglycerin Aspirin (MONA)

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines Laurent Macle, MD,

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation Ratika Parkash, MD, MSc, François Philippon,

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Volume 137, Issue 2, Pages (February 2010)

Atrial Fibrillation in the 21st Century: A Current Understanding of Risk Factors and Primary Prevention Strategies Arthur R. Menezes, MD, Carl J. Lavie,

Karlyn A. Martin, MD, Craig R. Lee, PharmD, PhD, Timothy M

Sandra Lauck, RN, PhD, Dion Stub, MD, PhD, John Webb, MD

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Overview of Current Learning Theories for Medical Educators

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

The Paucity of Data Addressing the Effects of Cardiac Rehabilitation on Mortality and Morbidity in Women Gabriela Lima de Melo Ghisi, PhD, Gabriela Suéllen.

The State of Affairs for Cardiovascular Health Research in Indigenous Women in Canada: A Scoping Review Stephanie A. Prince, PhD, Lisa A. McDonnell,

What Palliative Care-Related Problems Do Patients Experience at HIV Diagnosis? A Systematic Review of the Evidence Victoria M. Simms, MSc, Irene J. Higginson,

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines Laurent Macle, MD,

Health Care Use and Associated Time and Out of Pocket Expenditures for Patients With Cardiovascular Disease in a Publicly Funded Health Care System Saba.

Comparative Evaluation of 2-Hour Rapid Diagnostic Algorithms for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T Andrew D. McRae,

James L. Cox, MD, Niv Ad, MD, Terry Palazzo, RN, MS

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Atul Verma, MD, John A. Cairns, MD, L.

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Jason G. Andrade, MD, Atul Verma, MD,

Amy C. Arnold, PhD, MSCI, Satish R. Raj, MD, MSCI

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Atrial Fibrillation and Heart Failure

Stop Talking ‘Dirty’: Clinicians, Language, and Quality of Care for the Leading Cause of Preventable Death in the United States John F. Kelly, PhD, Sarah.

The Cox maze IV procedure: Predictors of late recurrence

Patient attitudes toward issues of environmental health

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter Atul Verma, MD, FRCPC,

National Trends in Ambulatory Oral Anticoagulant Use

A Review of Learner Impact on Faculty Productivity

Late to the Feast: Primary Care and US Health Policy

Richard Severin, PT, DPT, CCS, Shane A. Phillips, PT, PhD, FAHA

Excessive Prolongation of Coagulation Time During Treatment With Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation Mihoko Kawabata,

A New Algorithm for the Diagnosis of Hypertension in Canada

Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.

Erratum Canadian Journal of Cardiology

Research and research funding in vascular surgery

SAFETY AND EFFICACY OF DABIGATRAN COMPARED TO BRIDGED WARFARIN FOR PERIPROCEDURAL ANTICOAGULATION IN PATIENTS UNDERGOING RADIOFREQUENCY ABLATION FOR.

Subodh Verma, MD, PhD, Milan Gupta, MD, Paul M. Ridker, MD

CLINICAL OUTCOMES OF ADULT HEART TRANSPLANT RECIPIENTS CARED FOR AT A LOW-VOLUME NON-TRANSPLANT CENTER K.H. Wallace, S.R. Zieroth, A. Schaffer, L.A.

Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 1: Non-ST–Segment.

COMPARISON OF OUTCOMES FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN ONTARIO AS REPORTED BY THE CARDIAC CARE.

Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation Finlay A. McAlister,

Commentary: Judgment day: Should you add atrial fibrillation ablation?

J. David Spence, BA, MBA, MD Canadian Journal of Cardiology

Mobile Medicine: Digital Dynamo or Virtual Vaporware

Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events? D. George Wyse,

Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older? Jean-Eric Tarride, PhD, F. Russell Quinn,

Presentation transcript:

Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation James A. Stone, MD, PhD, Karen M. Earl, MSc, Blair J. O'Neill, MD, Mukul Sharma, MD, MSc, Thao Huynh, MD, MSc, PhD, Kori Leblanc, PharmD, Richard Ward, MD, Philip A. Teal, MD, Jafna L. Cox, BA, MD Canadian Journal of Cardiology Volume 30, Issue 10, Pages 1245-1248 (October 2014) DOI: 10.1016/j.cjca.2014.08.002 Copyright © 2014 The Authors Terms and Conditions

Figure 1 Canadian Institutes of Health Research knowledge to action process. Reproduced from Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/39033.html#Knowledge-Users). Canadian Journal of Cardiology 2014 30, 1245-1248DOI: (10.1016/j.cjca.2014.08.002) Copyright © 2014 The Authors Terms and Conditions